Dynavax Technologies (DVAX) EBIAT: 2009-2025
Historic EBIAT for Dynavax Technologies (DVAX) over the last 17 years, with Sep 2025 value amounting to $26.9 million.
- Dynavax Technologies' EBIAT rose 53.05% to $26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.4 million, marking a year-over-year decrease of 311.94%. This contributed to the annual value of $27.3 million for FY2024, which is 527.44% up from last year.
- Dynavax Technologies' EBIAT amounted to $26.9 million in Q3 2025, which was up 43.83% from $18.7 million recorded in Q2 2025.
- Over the past 5 years, Dynavax Technologies' EBIAT peaked at $128.8 million during Q2 2022, and registered a low of -$96.1 million during Q1 2025.
- Its 3-year average for EBIAT is -$2.7 million, with a median of $7.0 million in 2024.
- As far as peak fluctuations go, Dynavax Technologies' EBIAT spiked by 3,587.88% in 2022, and later crashed by 1,001.93% in 2025.
- Dynavax Technologies' EBIAT (Quarterly) stood at $99.8 million in 2021, then slumped by 32.12% to $67.7 million in 2022, then slumped by 99.68% to $219,000 in 2023, then skyrocketed by 3,119.18% to $7.0 million in 2024, then skyrocketed by 53.05% to $26.9 million in 2025.
- Its EBIAT stands at $26.9 million for Q3 2025, versus $18.7 million for Q2 2025 and -$96.1 million for Q1 2025.